FDA Investigator Dyana K Stone
Dyana K Stone has inspections in 1 countries as of 17 Aug 2023. Dyana K Stone has collaborated with a combinined 3552 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
69
Last Inspection Date:
17 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam R Cooke,
Ademola O Daramola,
Aimee K Contreras,
Alan P Kurtzberg,
Alexandra B Pitkin,
Aliza Chalapong Asawesna,
Altino C Mckelvey,
Amanda L Fyles,
Amir Alavi,
Ana Djurdjevic,
Andrew S Limson,
Angela Shepas,
Arsen Karapetyan,
Ashley S Ertzman,
Babajide Michael Osunsanmi,
Belinda E Clifton,
Bichsa T Tran,
Binh T Nguyen,
Bonnie I Needleman,
Bowman,
Bradley E Tufto,
Brian P Putz,
Brian Ravitch,
Bryan A Galvez,
Burnsb,
Bush,
Calvin B Koerner,
Carla J Lundi,
Carla M Fernandez Borges,
Carol B Czerniak,
Carr Sharpe,
Caryn M Everly,
Caryn M Mcnab,
Cathryn M Groehnert,
Celena Ngo,
Charlotte P Chang,
Christina D Mello,
Comyar Shoghi,
Danielle M Didonna,
Darren S Brown,
Darrin E Davis,
David G Whitman,
David H Hsu,
David Y Hernandez,
Davis,
Deborah G Park,
Deborah W Hsu,
Debra J Fracassa,
Dejon N Harris,
Desiree C Iya,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Doretha M Wilson,
Durell L Giles,
Eileen T Dupont,
Ellen N Stewart,
Erik D Sandvig,
Firasat H Ghori,
Francisco,
Frederick Fricke,
Frederick L Fricke,
Gabriel Craig,
Garciam,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Grace P Santos,
Greg K Keshishyan,
Gregory A Berg,
Henry E Carrillo,
Herminio C Francisco,
Hinh T Nguyen,
Hoover,
Hugh Grimoldby,
Jacob W Reynolds,
James A Barreto,
James A Lentz,
James P Stallings,
Janet Blount,
Janet D Bart,
Jazmine M Welcher,
Jeff M Uriarte,
Jeffery A Johnson,
Jennie J Fan,
Jennifer M Gogley,
Jeremy Beber,
Jessica B Clark,
Jinnie Kokiatkulkij,
Joe X Phillips,
Joey V Quitania,
John A Gonzalez,
John A Liu,
John P Jorgensen,
Jolanna A Norton,
Joseph C Francisco,
Joseph C Yen,
Joseph H Lam,
Joseph S Fanelli,
Joseph X Phillips,
Juan J Casado,
Judy C Nepsa,
Ka L Wong,
Karen L Bauer,
Katherine E Jacobitz,
Kawshalya Pathiraja,
Kevin Lee,
Kevin T Gerrity,
Kham Phommachang,
Kham Phommachanh,
Kibily D Dembele,
Kim Lthomas Cruse,
Kimberly M Lichter,
Lacresha Menifee,
Lakecha N Lewis,
Lanita F Kelley,
LCDR Wilfred A Darang,
Lester O Boian,
Leticia I Romero,
Lilly O Barton,
Lin Liu,
Linda F Murphy,
Ling Yul Liu,
Marco A Solorio,
Marco S Esteves,
Marcus F Yambot,
Mariza M Jafary,
Mariza M Jalary,
Mark C Saale,
Maxyne T Lam,
Mei Chen Mu,
Michael D Garcia,
Michael D Staake,
Michael F Schuette,
Michael J Chan,
Michael S Call,
Mihaly S Ligmond,
Monica R Maxwell,
Natalie J Ayoub,
Natalie J Reese,
Naveen B Walker,
Ngoc T Le,
Nianna C Burns,
Nianna M Capalia,
Omotunde O Osunsanmi,
Pabhu P Raju,
Patricia F Alberico,
Phal K Chhun,
Phillip L Toy,
Prabhu P Raju,
Randy L Elsberry,
Raymond T Oji,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Romero,
Ruben G Abrajano,
Sandersk,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sara Jdent Acosta,
Sarah A Hassas,
Sarah R Barker,
Scott J Matsuda,
Scott K Zika,
Sean P Desbrow,
Shannon B Ruelle,
Sharon K Ferguson,
Sharon S Ho,
Sonya L Karsik,
Sparky L Bartee,
State Agency,
Steven E Porter, Jr,
Sundy V Sedwick,
Sundy Ven,
Susanna N Choi,
Sylvia A Thomas,
Tamala P Bogan,
Tamala P Magee,
Tamara L Alexander,
Tammy Vasquez Hancock,
Tanya E Malais,
Tara L Stockton,
Tawny L Colling,
Terrance L Thomas,
Terri L Dodds,
Thao T Kwan,
Theresa Kirkham (NMI),
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Tuan D Tran,
Uttaniti Limchumroon (Tom),
Vanessa R Muller,
Vashti E Bocker,
Victoria V Nadershahi,
Virgilio F Pacio, CSO,
Walden H Lee,
Walden Lee,
Wayne L Jefferson,
William D Boden,
Yolanda D Mitchell Lee,
Yumi J Hiramine,
Yvette Mlacour Davis,
Yvonne C Wilkes,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary R Harris,
Zenja D Woodley
Dyana K Stone's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2011 | FDA 483 | Moorpark Lay Ranch - Form 483, 2011-06-24 |
| February, 2010 | EIR | Teva Parenteral Medicines, Inc. - EIR, 2010-02-01 |
| March, 2009 | FDA 483 | P & L Development, LLC - Form 483, 2009-03-27 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more